[
    {
        "header": "Abstract",
        "images": [
            {
                "img": "https://arxiv.org/html/2506.02327/x1.png",
                "caption": "Figure 1:Formulation of Medical World Model.It integrates imaging observations with perception modules to form an initial state, which is then processed by a progression generative model to predict future states of disease under different treatment conditions. Recovery-conditioned policies guide treatment decisions, creating a feedback loop for optimizing clinical interventions.",
                "position": 119
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x2.png",
                "caption": "Figure 2:Overview of TACE Protocol Exploration by Medical World Model.(1) GPTs (Policy Model): construct the TACE action combos by the observation of pre-treatment CT, integrating clinical guidelines and policies.\n(2) Tumor Generative Model (Dynamics Model): simulates post-treatment tumor based on different TACE intervention protocols, predicting treatment outcomes.\n(3) Survival Analysis Model (Heuristic Function): assesses risk scores from both simulated post-treatment CT and pre-treatment CT to determine the most effective TACE protocol.\nNote that the 3D tumor masks (colored in red) can be extracted using a well-trained segmentation network (as Assistant Model).\nThe framework enables visually trackable protocol optimization by iterating between clinical policy guidance, generative modeling, and survival analysis.",
                "position": 195
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x3.png",
                "caption": "Figure 3:Dynamics Model based on Tumor Generative Model.The training framework consists of three parts:(a) Radiotherapy Report Extraction and Generation: GPT-4o and Deepseek-R1 extract key treatment details from radiotherapy reports and generate corresponding TACE surgical actions.(b) Post-Treatment Tumor Generation: An Action-driven 3D Diffusion Model is conditioned by fused action embeddings and attenuated CT features to generate post-treatment tumors that simulate treatment outcomes.(c) Combo Contrastive Learning (CCL): The model learns from treatment variations by pushing apart dissimilar combos and pulling together similar ones, improving its ability to generate realistic and action-aware post-treatment tumor appearances.",
                "position": 238
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x4.png",
                "caption": "Figure 4:Examples of Visual Turing Test. We present one real tumor alongside examples of synthetic tumors that were correctly and incorrectly identified. Ared dotindicates the radiologist classified the post-treatment tumor as synthetic, while agreen dotsignifies it was identified as real.",
                "position": 612
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x5.png",
                "caption": "Figure 5:Performance of heuristic function on survival analysis.The first three heatmaps show the true risk distribution, Cox model predictions, and our heuristic function predictions. The last two depict prediction errors, with lower MSE (0.2142) for our model compared to the Cox model (0.3550), demonstrating improved accuracy in capturing localized risk patterns.",
                "position": 616
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x6.png",
                "caption": "Figure 6:Kaplan-Meier Survival Curves: Radiomics-based Cox Model[67]vs. our deep model.The left shows the survival curves predicted by the Cox model based on Radiomics features. The right presents the survival curves from our model based on deep features, which achieves a significantly higher c-index of 0.752 and a log-rank p-value of6.74‚Å¢e‚àí56.74ùëí56.74e-56.74 italic_e - 5, demonstrating a stronger ability to distinguish between high- and low-risk groups. Shaded areas represent confidence intervals.",
                "position": 633
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x7.png",
                "caption": "Figure 7:Example of MeWM intervention in clinical applications.The radiologist initially proposes a TACE protocol with Raltitrexed, Lobaplatin, Idarubicin, and embolization using Lipiodol and Gelatin Sponge. MeWM simulates a protocol with Raltitrexed, Lobaplatin, and Lipiodol. After intervention, the optimized protocol removes Idarubicin but restores Gelatin Sponge, aligning with gold action.",
                "position": 802
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x8.png",
                "caption": "Figure 8:Example of HCC-TACE-Seg dataset. The first row shows HCC Pre-CT images, and the second row shows HCC Post-CT images. The red mask represents the liver, while the green mask represents the HCC tumor.",
                "position": 1951
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x9.png",
                "caption": "Figure 9:Example of HCC-TACE dataset. The first row shows HCC Pre-CT images, and the second row shows HCC Post-CT images. The red mask represents the liver, while the green mask represents the HCC tumor. In post-treatment CT imaging of HCC, particularly after Transarterial Chemoembolization (TACE), the viable tumor region and its enhancement intensity decrease due to Lipiodol accumulation and treatment-induced necrosis. Lipiodol appears hyperdense (bright) on post-treatment CT, indicating areas that have been successfully embolized.",
                "position": 2109
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x10.png",
                "caption": "Figure 10:Policy model prompt template for our dataset.",
                "position": 2191
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x11.png",
                "caption": "Figure 11:VLM prompt template for our dataset.",
                "position": 2195
            },
            {
                "img": "https://arxiv.org/html/2506.02327/x12.png",
                "caption": "Figure 12:VLM prompt template for HCC-TACE-Seg.",
                "position": 2199
            }
        ]
    },
    {
        "header": "Appendix",
        "images": []
    }
]